13 November 2022 false No description of principal activity Taxfiler 2024.5 14480699business:PrivateLimitedCompanyLtd2022-11-132023-11-30 144806992022-11-12 144806992022-11-132023-11-30 14480699business:AuditExempt-NoAccountantsReport2022-11-132023-11-30 14480699business:FilletedAccounts2022-11-132023-11-30 144806992023-11-30 14480699business:Director12022-11-132023-11-30 14480699business:RegisteredOffice2022-11-132023-11-30 14480699core:PreviouslyStatedAmount2023-11-30 14480699business:SmallEntities2022-11-132023-11-30 14480699countries:EnglandWales2022-11-132023-11-30 iso4217:GBP xbrli:pure
Company Registration No. 14480699 (England and Wales)
SPARROWHAWK PHARMA LIMITED Unaudited accounts for the period from 13 November 2022 to 30 November 2023
SPARROWHAWK PHARMA LIMITED Unaudited accounts Contents
Page
- 2 -
SPARROWHAWK PHARMA LIMITED Company Information for the period from 13 November 2022 to 30 November 2023
Director
Umer Ayyaz
Company Number
14480699 (England and Wales)
Registered Office
14 ALTAR DRIVE BRADFORD BD9 5QD ENGLAND
Accountants
AMS Accountants SBU Ltd Wesley Place Wellington Road Dewsbury WF13 1HD
- 3 -
SPARROWHAWK PHARMA LIMITED Statement of financial position as at 30 November 2023
2023 
Notes
£ 
Net current assets
- 
Net assets
- 
Shareholders' funds
- 
For the period ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 31 July 2024 and were signed on its behalf by
Umer Ayyaz Director Company Registration No. 14480699
- 4 -
SPARROWHAWK PHARMA LIMITED Notes to the Accounts for the period from 13 November 2022 to 30 November 2023
1
Statutory information
SPARROWHAWK PHARMA LIMITED is a private company, limited by shares, registered in England and Wales, registration number 14480699. The registered office is 14 ALTAR DRIVE, BRADFORD, BD9 5QD, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Average number of employees
During the period the average number of employees was 1.
- 5 -